Accelerate Your ADC Journey: Filling The Need For Integrated Bioconjugate Solutions

Unlock the potential of your Antibody-Drug Conjugate (ADC) drug development journey with Lonza’s latest integrated solution: Ibex^® Design ADC. In this webinar, we explore how Lonza is further reshaping the ADC landscape by introducing new Drug Product capabilities that enable end-to-end development and manufacturing of cytotoxic bioconjugates.

Discover how, through the innovative Ibex^® Design solution, Lonza can accelerate your CMC path to IND in just 15 months, encompassing all stages from cell line development to ADC Drug Substance and through to Drug Product.

View this webinar to:

• Gain insights into Lonza’s new DP capabilities in cytotoxic development and manufacturing
• Explore the common pitfalls faced by ADC drug developers
• Understand how Lonza can bring substantial benefits to your ADC program and accelerate your IND timeline